PlainPharmaWatch

CMS Open Payments · Program Year 2024

Exeltis, USA Inc.

Exeltis, USA Inc. reported $7,688,015.46 across General Payments, Research, and Ownership to 17,662 physicians and teaching hospitals across 18,860 transactions.

See the rankings → How this is sourced
$7.7M Top quartile payer
All-tracks total
18,860 Top 10% volume
Transactions
17,662 Top 10% reach
Recipients
+$65.1K
General Payments vs PY2023

Exeltis, USA Inc. reported $7,688,015.46 across all CMS Open Payments tracks (General + Research + Ownership) to 17,662 physicians and teaching hospitals in Program Year 2024 - ranking #212 of 1,925 reporting manufacturers (0.1% of the all-tracks industry total); General Payments alone were $703,992.64, averaging $435.29 per recipient.

How Exeltis, USA Inc.'s $7.7M all-tracks total breaks down

Exeltis, USA Inc.'s payment reach score

Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.

Overall reach score

B

83/100

Total payments

B

81/100

Transaction volume

A

100/100

Physician reach

A

100/100

Payment type diversity

D

50/100

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer exeltis-usa-inc Exeltis, USA Inc.

$7.7M · #212/1,925 · 0.1% industry · PY2024

  • TOT $7.7M
  • RANK #212
  • SHARE 0.1%
  • TXN 18,860
  • RCP 17,662
  • CAT 4
  • GEN $704.0K
  • ΔGEN +$65.1K
  • TOP1 17.4%
  • PY 2024

Volume peers

Nearest volume peer: Integrity Orthopaedics, Inc. ($7.7M)

Integrity Orthopaedics, Inc.$7.7MExeltis, USA Inc. (this)$7.7MPenumbra, Inc.$7.7MAsklepios Biopharmaceutical …$7.6MDuraStat LLC$7.6M
All-tracks payment totals near Exeltis, USA Inc. (CMS Open Payments PY2024)

Exeltis, USA Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Exeltis, USA Inc.'s CMS-reported General Payments increased by $65.1K (+10.2%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: EXELTIS, USA INC.PY2023: EXELTIS, USA INC.PY2024: Exeltis, USA Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$638.9KPY2024$704.0K
PY2023
$638,870.38
PY2024
$703,992.64

What the Data Shows for Exeltis, USA Inc.

The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Exeltis, USA Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.

"Food and Beverage" leads the 4-category general-payment breakdown below at $345.7K (49.1% of General Payments, 17,597 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

"Food and Beverage" leads Exeltis, USA Inc.'s 4-category general-payment breakdown at $345.7K, 49.1% of the reported total.

Exeltis, USA Inc. reports 4 general-payment categories - the top three are Food and Beverage (49.1%), Consulting Fee (29.2%), and Compensation for Services Other Than Consulting (19.8%). The remaining 1 category make up 1.9% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.

How Exeltis, USA Inc. divides its payments

General-payment categories, ordered by reported total

1. Food and Beverage$345.7K2. Consulting Fee$205.3K3. Compensation for Services…$139.2K4. Travel and Lodging$13.7K
Payment Type Amount Transactions
Food and Beverage $345.7K 17,597
Consulting Fee $205.3K 20
Compensation for Services Other Than Consulting $139.2K 32
Travel and Lodging $13.7K 13

Recipient Concentration in General Payments

The five largest recipient relationships account for $302,068.57 (42.9%) of $703,992.64 in this company's General Payments records across 9,522 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Exeltis, USA Inc.

The five named recipients with the highest reported General Payments from this company

Catherine Hansen$122.3KYoussef Mouhayar$83.6KMichael Krychman$46.9KJennifer Elliott$27.2KJordan W Neighbors$22.0K
  1. 1

    Catherine Hansen

    $122,306.89 across 36 reported transactions

  2. 2

    Youssef Mouhayar

    $83,643.54 across 17 reported transactions

  3. 3

    Michael Krychman

    $46,946.13 across 1 reported transactions

  4. 4

    Jennifer Elliott

    $27,208.29 across 11 reported transactions

  5. 5

    Jordan W Neighbors

    $21,963.72 across 21 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Spend vs. Concentration

Exeltis, USA Inc. ranks #212 of 1,925 by total payments (top 11% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,278 of 1,838 by HHI (bottom 31% least concentrated), a wider distribution than most similarly sized payers.

00.81.62.43.1509514.5520525.5531Total payments ($M)Concentration (HHI, 0-10,000)
Exeltis, USA Inc. (highlighted) among its 12 nearest HHI-concentration neighbors, Program Year 2024. Dashed lines mark this neighborhood's median payment total and median HHI. Hover a point for the company name. Source: company_concentration (CMS Open Payments general-payment recipients).
View all 12 companies in this HHI neighborhood as a list

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Exeltis, USA Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Exeltis, USA Inc..

EnableCV Inc.

HHI 517

Sarepta Therapeutics, Inc.

HHI 522

Life Spine, Inc.

HHI 523

Ostial Corporation

HHI 515

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Exeltis, USA Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Put this to use

Exeltis, USA Inc. ranks #212 of 1,925 by all-tracks total payments, led by "Food and Beverage".

Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Exeltis, USA Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.